Article
LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome.
Advances in therapy - 1 Sept 2008
Blum Kenneth, Chen Amanda L C, Chen Thomas J H, Rhoades Patrick, Prihoda Thomas J, Downs B William, Waite Roger L, Williams Lonna, Braverman Eric R, Braverman Dasha, Arcuri Vanessa, Kerner Mallory, Blum Seth H, Palomo Tomas
Abstract excerpt
INTRODUCTION: This study systematically assessed the weight management effects of a novel experimental DNA-customized nutraceutical, LG839 (LifeGen, Inc., La Jolla, CA, USA). METHODS: A total of 1058 subjects who participated in the overall D.I.E.T. study were genotyped and administered an LG839 variant based on polymorphic outcomes. A subset of 27 self-identified obese subjects of Dutch descent, having the same...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.